Prognostic signatures in breast cancer: correlation does not imply causation
- PMID: 22713235
- PMCID: PMC3446329
- DOI: 10.1186/bcr3173
Prognostic signatures in breast cancer: correlation does not imply causation
Abstract
Testing the statistical associations between microarray-based gene expression signatures and patient outcome has become a popular approach to infer biological and clinical significance of laboratory observations. Venet and colleagues recently demonstrated that the majority of randomly generated gene signatures are significantly associated with outcome of breast cancer patients, and that this association stems from the fact that a large proportion of the transcriptome is significantly correlated with proliferation, a strong predictor of outcome in breast cancer patients. These findings demonstrate that a statistical association between a gene signature and disease outcome does not necessarily imply biological significance.
Similar articles
-
Genes and functions from breast cancer signatures.BMC Cancer. 2018 Apr 27;18(1):473. doi: 10.1186/s12885-018-4388-4. BMC Cancer. 2018. PMID: 29699511 Free PMC article.
-
Prognostic gene expression signatures of breast cancer are lacking a sensible biological meaning.Sci Rep. 2021 Jan 8;11(1):156. doi: 10.1038/s41598-020-79375-y. Sci Rep. 2021. PMID: 33420139 Free PMC article.
-
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.PLoS One. 2012;7(9):e45831. doi: 10.1371/journal.pone.0045831. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049873 Free PMC article.
-
CCR 20th Anniversary Commentary: Gene-Expression Signature in Breast Cancer--Where Did It Start and Where Are We Now?Clin Cancer Res. 2015 Nov 1;21(21):4743-6. doi: 10.1158/1078-0432.CCR-14-3127. Clin Cancer Res. 2015. PMID: 26527804 Review.
-
Molecular signatures in breast cancer.Methods. 2017 Dec 1;131:135-146. doi: 10.1016/j.ymeth.2017.06.032. Epub 2017 Jun 29. Methods. 2017. PMID: 28669865 Review.
Cited by
-
Genes and functions from breast cancer signatures.BMC Cancer. 2018 Apr 27;18(1):473. doi: 10.1186/s12885-018-4388-4. BMC Cancer. 2018. PMID: 29699511 Free PMC article.
-
Translating metastasis-related biomarkers to the clinic--progress and pitfalls.Nat Rev Clin Oncol. 2013 Mar;10(3):169-79. doi: 10.1038/nrclinonc.2013.4. Epub 2013 Feb 5. Nat Rev Clin Oncol. 2013. PMID: 23381003 Review.
-
Pan-Cancer Upregulation of the FOXM1 Transcription Factor.Genes (Basel). 2025 Jan 6;16(1):56. doi: 10.3390/genes16010056. Genes (Basel). 2025. PMID: 39858603 Free PMC article.
References
-
- Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. doi: 10.1038/35021093. - DOI - PubMed
-
- Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical